Response Genetics Q2 revenues up 24%

|About: Response Genetics, Inc. (RGDX)|By:, SA News Editor

Response Genetics (NASDAQ:RGDX) Q2 results: Revenues: $5.3M (+24.1%); Operating Expenses: $3.9M (-19.2%); Operating Loss: ($1.3M) (+59.0%); Net Loss: ($1.3M) (+58.7%); Loss Per Share: ($0.04) (+50.0%); Quick Assets: $8.1M (+281.4%).

No financial guidance given.